What amount sold does ADIPO THERAPEUTICS, LLC report in Form D filings?

The latest linked filings report $6M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ADIPO THERAPEUTICS, LLC's most recent SEC filing?

ADIPO THERAPEUTICS, LLC's most recent Form D filing was on 2024-12-11.

How many investors does ADIPO THERAPEUTICS, LLC have?

The most recent Form D filing lists 20 investor(s).

What type of securities does ADIPO THERAPEUTICS, LLC offer?

ADIPO THERAPEUTICS, LLC's SEC Form D filings indicate equity offerings.

ADIPO THERAPEUTICS, LLC

CIK: 0001823434·Biotechnology·Indianapolis, IN·Limited Liability Company

Reported Sold

$5,967,337

Total Filings

Identified Offerings

Last Filed

Dec 11, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Dec 11, 2024Form D — New notice

Reported sold: $4,717,337 · Target: $14,717,337

Rule 506(b)·20 investors

Sep 2, 2020Form D — New notice

Reported sold: $1,250,000 · Target: $2,000,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$5,967,337

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Meng Deng

Related Person

Appears on 1 filing

Michael Clayman

Related Person

Appears on 1 filing

Karen Wurster

Related Person

Appears on 1 filing

Keith Johns

Related Person

Appears on 1 filing

Meng Deng

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 11, 2024	New	$14,717,337	$4,717,337	20
Sep 2, 2020	New	$2,000,000	$1,250,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

28bio, Inc.

Biotechnology

Offering target: $8,524,945

Filed Oct 29, 2026